Overview
Indications
BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE is indicated for the management of the symptom complex of tension (or muscle contraction) headache, when non-opioid analgesic and alternative treatments are inadequate.
Contraindications
When this intervention should not be used
BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE is contraindicated for: BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE is also contraindicated in patients with: 5.6 Warnings and Precautions () All children younger than 12 years of age [see] 5.6 Warnings and Precautions () Postoperative mana
Indications & Related Conditions
Conditions associated via SNOMED clinical relationships
Administration & Protocol
Dosing, route, and treatment protocol
Detailed dosage and administration information is available in the full FDA drug label.
View full prescribing information on DailyMedMonitoring & Follow-Up
Biomarkers relevant to this intervention via related conditions
Clinical Trials
25 trials linked to this intervention
Recent Trials
Efficacy of Proprietary Cherry Juice Blend in Osteoarthritis of the Knee
An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout
Allopurinol Outcome Study
Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol
Research Evidence
Published studies and systematic reviews
Research data from MEDLINE/PubMed
Benefits & Expected Outcomes
Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.
Risks & Side Effects
Adverse reaction and safety data for this drug is sourced from the FDA-approved label.
View adverse reactions & drug interactions on DailyMedRelated Symptoms
Symptoms associated with conditions this intervention addresses
No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.
Alternatives & Comparisons
Alternative treatments, comparison data, and clinical decision support are pending physician authorship.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Do not start, stop, or change any treatment without consulting your healthcare provider.
Specialists
Providers who commonly manage this intervention
Quick Facts
- Type
- Substance / Medication
- Fully Specified Name
- Aspirin (substance)
- SNOMED CT
- 387458008
- UMLS CUI
- C0004057
- RxNorm CUI
- 1191
- Labeler
- Amneal Pharmaceuticals of New York, LLC
Clinical Data
This intervention maps to 12 entities in the Healos knowledge graph.
Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.